BILIARY TRACT CARCINOMA
Clinical trials for BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise in bile duct cancer battle
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy helps people with advanced bile duct or gallbladder cancer live longer. Over 1,000 participants received either the drug combo or a placebo plus chemo. The main goal was to see if the p…
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 16, 2026 23:33 UTC
-
New combo shows promise in bile duct cancer battle
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy helps people with advanced bile duct cancer live longer. It involved 158 Chinese adults whose cancer had spread or could not be removed by surgery. The main goal was to see if the combi…
Matched conditions: BILIARY TRACT CARCINOMA
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:55 UTC